FDA advisory panel voted to lift restrictions on peptides BPC-157, TB-500, KPV, MOTS-c, epitalon & semax, backed by RFK Jr., despite FDA staff safety concerns.
After two days of meetings, an FDA advisory committee last week voted to lift restrictions on six popular health and wellness peptides, setting aside FDA …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr.
FDA panel recommends easing restrictions on several peptides, including BPC-157
RFK Jr.'s peptide push narrowly gains backing from FDA advisers despite objections from scientists | Fortune
An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition
FDA Panel Clears the Way for 6 Banned Peptides. Here's What They're Claimed to Do
FDA panel narrowly backs unapproved peptide drugs favoured by RFK Jr and wellness influencers
US health panel recommends easing restrictions on controversial peptides
FDA Panel Finds a Peptide It Doesn't Like
In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
FDA panel reviewing some peptides to consider loosening regulations for unapproved therapies
FDA advisory panel voted 8-6 to recommend compounding pharmacies access BPC-157, opposing FDA scientists' safety concerns. RFK…
Votes go against agency scientists' recommendation to keep them off the compounding list
The panel went against the conclusions of the agency’s career scientists, who said there was not enough evidence to support the…
The panel voted 8-6 despite agency scientists’ warnings that certain peptide chemicals lack evidence of safety or effectiveness.
Ahead of an FDA advisory committee meeting to discuss lifting restrictions on seven popular peptides, agency reviewers have…
The group met on July 24 to vote on whether compounding pharmacies could legally dispense certain peptides.
